Skip to main content

Table 4 Diagnostic yield for colorectal cancer and significant colonic lesion detection according to the COLONPREDICT classification in the derivation cohort

From: Development and external validation of a faecal immunochemical test-based prediction model for colorectal cancer detection in symptomatic patients

 

Low riska

Intermediate riskb

High riskc

Number of patients (%)

39.5

29.6

30.9

Colorectal cancer

PPV (%)d

0.2 (0.0– 1.1)

4.4 (2.8–6.8)

40.7 (36.7–45.9)

NNE (95 % CI)

603 (91–10,000)

22.6 (14.7– 35.7)

2.5 (2.2– 2.7)

OR (95 % CI)

1.0

27.8 (3.7–208)

413 (57.5–2961)

Advanced neoplasiae

PPV (%)d

7.1 (5.3– 9.6)

20.8 (17.2– 24.8)

58.1 (53.4– 62.5)

NNE (95 % CI)

14.1 (10.4– 18.9)

4.8 (4.0– 5.8)

1.7 (1.6– 1.9)

OR (95 % CI)

1.0

3.4 (2.3–5.0)

18.0 (12.6–25.8)

Significant colonic lesionf

PPV (%)d

8.5 (6.4– 10.0)

24.5 (20.7–28.8)

61.4 (56.9–65.8)

NNE (95 % CI)

11.8 (10.0–15.6)

4.1 (3.5– 4.8)

1.6 (1.5– 1.7)

OR (95 % CI)

1.0

3.5 (2.5–5)

17.2 (12.3–24.3)

  1. aLow-risk cohort: COLONPREDICT score <3.5
  2. bIntermediate-risk cohort: COLONPREDICT score ≥3.5 and <5.6
  3. cHigh-risk cohort: COLONPREDICT score ≥5.6
  4. dValues are expressed as the percentage and its 95 % confidence interval
  5. eColorectal cancer, advanced adenoma (≥10 mm, villous histology, high-grade dysplasia)
  6. fColorectal cancer, advanced adenoma (≥10 mm, villous histology, high-grade dysplasia), polyposis (>10 polyps of any histology), colitis (any aetiology), polyps ≥10 mm, complicated diverticular disease, colonic ulcer and/or bleeding angiodysplasia
  7. CI confidence interval, NNE number needed to endoscopy, OR odds ratio. PPV positive predictive value